Together with the previously established role of TRAF4 in binding to the C terminal juxtamembrane region of HER1(EGFR) and participating in EGFR signaling activation [21], our findings further support the oncogenic roles of TRAF4 in breast cancer through increasing the HER2 signaling pathways. This evidence concerns the gene ERBB2 and breast cancer.